The present invention relates generally to surgical devices and relates more specifically to a percutaneous transluminal angioplasty device.
The vascular bed supplies a constant flow of oxygen-rich blood to the organs. If plaque builds up in these vessels, blockages can develop, reducing blood flow to the organs and causing adverse clinical symptoms, up to and including fatality.
Angioplasty is a catheter-based procedure performed by a physician to open up a blocked vessel and restore blood flow. An entry site is opened, for example in the patient's groin, arm, or hand, and a guide wire and catheter are advanced under fluoroscopic guidance to the location of the blockage. A catheter having a small balloon adjacent its distal end is advanced under fluoroscopic guidance until the balloon lies within the stenosed region. The balloon is then inflated and deflated one or more times to expand the stenosed region of the artery.
Since diseased vessels are comprised of a range of material from early-stage thrombosis to late-stage calcified plaque, angioplasty can release embolic particles downstream from the stenosed location. These embolic particles can result in adverse clinical consequences. It has been shown that it is beneficial to trap these embolic particles to prevent them from traveling downstream with blood flow to the capillary bed (e.g., Bairn D S, Wahr D, George B, et al., Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts, Circulation 2002; 105:1285-90).
In addition to balloon angioplasty, stenoses may also be treated with stents and with mechanical thrombectomy devices. These devices are also prone to releasing embolic particles downstream from the stenosed location.
There are systems available today that are used to catch these embolic particles. They are primarily filter systems or occlusion balloon systems built on a guidewire. These systems have shortcomings related to simplicity of use and crossing tight lesions with a filter or balloon guidewire that is larger in diameter than the guide wire which is normally used. These embolic protection guidewires also have flexibility and stability problems that make the protected angioplasty procedure difficult in many cases. In the case of saphenous vein grafts, the problems relate specifically to aorto-ostial lesions, where the guidewire may not be long enough to provide support, or distal vein graft lesions, where there is not enough of a landing zone for the filter. The latter is a problem as currently available filter systems have a considerable distance between the treatment balloon and the distal filter. This distance is a problem not only in distal vein graft lesions, but also in arterial stenoses in which there is a side branch immediately after the stenosis. In such cases, the filter can often be deployed only distal to the side branch, thus leaving the side branch unprotected from embolic particles.
Stated generally, the present invention comprises a percutaneous transluminal angioplasty device with integral embolic filter. Because the filter is integral with the catheter of the angioplasty device, there is no need to insert a separate device into the vessel. Further, proper placement of the angioplasty balloon assures proper placement of the embolic filter.
Stated somewhat more specifically, the percutaneous transluminal angioplasty device of the present invention comprises an embolic filter mounted to the catheter shaft at a location distal to the angioplasty balloon, stent, or mechanical thrombectomy device. Thus the filter is downstream from the blockage and is properly positioned to capture embolic particles that may be set loose into the blood stream as the angioplasty procedure is performed. The embolic filter is normally collapsed against the catheter shaft to facilitate introduction and withdrawal of the device to and from the operative site. Once the angioplasty balloon, stent, or mechanical thrombectomy device is properly positioned, however, means operatively associated with the embolic filter are actuated to erect the filter to position a filter mesh across the lumen of the coronary artery.
In some embodiments the means for erecting the filter comprises a balloon which longitudinally displaces one end of the filter toward the other, causing longitudinal ribs to bow outward, thus erecting the filter mesh. In other embodiments the means for erecting the filter comprises a balloon interposed within the proximal and distal ends of the filter, whereby inflating the balloon will bias the ribs away from the catheter shaft, causing the ribs to bow outwardly to erect the filter mesh. In still other embodiments the means for erecting the filter comprises a pull wire attached to one end of the filter, such that pulling on the wire longitudinally displaces one end of the filter toward the other, causing longitudinal ribs to bow outward, thus erecting the filter mesh.
In one embodiment of the invention, a reservoir is provided at the distal tip of the filter so that when the device collapses for withdrawal, debris does not get pushed out of the filter.
Objects, features, and advantages of the present invention will become apparent upon reading the following specification, when taken in conjunction with the drawings and the appended claims.
Referring now to the drawings, in which identical numbers indicate identical elements throughout the various views,
Located between the angioplasty balloon 18 and the distal tip 14 of the catheter 12 is a collapsible filter 20. The filter 20 includes a proximal ring portion 22 and a distal ring portion 24. A plurality of elongated ribs 26 extend generally longitudinally between the proximal and distal rings 22, 24. These ribs can be made of a shape memory material, such as nitinol, and in their baseline position, these ribs are collapsed. A filter mesh 28 overlies the distal portion of the ribs 26. In the embodiment of
Means 34 are included for erecting and collapsing the filter 20 of the device 10 shown in
Referring now to
Referring now to
Referring now to
The embodiment 610 shown in
In the device 710 shown in
The device 810 shown in
The operation of the device 10 will now be explained with respect to
In
Referring now to
In
Of interest in
When removing the device 10 from the coronary artery, the preferred procedure is to deflate the angioplasty balloon 18 first, prior to collapsing the embolic filter 20. In this way, any embolic particles that are broken loose as the angioplasty balloon 18 deflates will be captured by the filter 20. The embolic filter balloon 20 is then deflated, permitting the ribs 26 and filter mesh 28 to collapse against the shaft 14 of the catheter 12. Any embolic particles captured by the mesh 28 are trapped against the shaft 14. The device 10 is then withdrawn over the guide wire 908 and removed from the patient's body.
In various peripheral vascular applications, it may be necessary to insert the catheter against the direction of blood flow (e.g., the aorta).
While the embodiment 1000 of
In
To retract the embolic filter 1120, a second, outer catheter 1190 is advanced over the catheter 1112, as shown in
To use the percutaneous angioplasty device 1210, the inner catheter is inserted into the outer catheter so that the embolic filter 1220 is collapsed within the distal end of the device, as shown in
When the angioplasty procedure has been completed, the angioplasty balloon 1218 is deflated, and the embolic filter 1220 is withdrawn back into the forward end of the outer catheter 1294. The outer and inner catheters 1294, 1295 are then withdrawn together from the patient.
In the foregoing embodiment a wire can be substituted for the inner catheter 1295 as a means for carrying the embolic filter 1220.
Referring now to
More specifically, the frame 1402 comprises a first plurality of longitudinal struts 1412 extending inward from one end ring 1404. A second plurality of longitudinal struts 1413 extends inward from the opposite end ring 1406. The second struts 1413 are circumferentially offset from the first struts 1412. A connecting plurality of intermediate struts 1414 link the adjacent ends of the longitudinal struts 1412, 1413. In the disclosed embodiment, the number of first longitudinal struts 1412 is equal to the number of second longitudinal struts 1413, and there are twice as many intermediate connecting struts 1414 as there are struts 1412 or struts 1413.
With further reference to
In the disclosed embodiment the intermediate struts 1414 form a serpentine-like pattern. A first end of intermediate strut 1414A is connected to a first end of intermediate strut 1414B by a loop portion. A second end of intermediate strut 1414B is connected to a second end of intermediate strut 1414C by another loop portion, and so on. In the disclosed embodiment, the longitudinal struts 1412, 1413 are connected to the intermediate struts 1414 at the loop portions.
Points of weakness 1420 are formed on the support frame 1402 in strategic locations to facilitate controlled bending of the frame 1402. In the disclosed embodiment these points of weakness comprise points of reduced cross-sectional area. Further, in the disclosed embodiment these points of weakness are formed at the connection points between the rings 1404, 1406 and the longitudinal struts 1412, 1413 and at the connection between the longitudinal struts 1412, 1413 and intermediate struts 1414. Because of the narrow width at the connection points the longitudinal struts 1412, 1413 can flare open in the radial direction, while simultaneously expanding causing the intermediate struts 1414 to expand radially.
When the proximal and distal rings 1404, 1406 are brought toward one another, such as by any of the mechanisms hereinabove described, the filter frame 1402 assumes an expanded configuration as shown in
With further reference to
As further illustration that the second struts 1413A-D are circumferentially out of alignment with the first struts 1412A-D,
The filter membrane 1700 is attached to a support frame, such as the frames 1400, 1500, or 1600 hereinabove described, such that it covers one end of the frame as well as the centrally located serpentine strut structure. The other set of longitudinal struts remain exposed. The filter membrane 1700 may be attached on the outside of the frame or on the inside of the frame. In addition, the proximal end of the membrane can be terminated at the proximal ring or can extend beyond the ring to attach to the shaft of the catheter.
The filters herein depicted are deployed by pulling or pushing an actuation wire or inflating an actuation balloon, depending on the type of catheter chassis being used. As the filter is erected the serpentine struts expand circumferentially. The filter membrane is then deployed. Upon removal of the actuation force the filter retracts to its normally closed position.
An advantage of the filter material is that its natural shape is in a closed or collapsed condition. The filter material stretches as the filter is erected and collapses to its normal condition when the frame is retracted. Therefore, the membrane has no permanent set during storage and can always be expanded to a correct size. Further, because the filter collapses under the resiliency of the filter material, the filter does not require a recovery sheath. If needed, however, a sheath may be used to further collapse the filter with embolic debris prior to retrieval.
Preferably, but not necessarily, the filters of the disclosed embodiment are characterized by a long filter body that opposes the vessel wall over a greater area, thus reducing the chance of leakage between the filter and the vessel wall.
In each of the foregoing examples, it will be appreciated that an angioplasty balloon is but one means for relieving a stenosis in a vessel. Stents, mechanical thrombectomy devices, or other suitable apparatus may be substituted for the angioplasty balloon and positioned on the catheter at a location proximal to the embolic filter. Thus any emboli loosened by the stent or mechanical thrombectomy device will be captured by the embolic filter in the same manner as described above with respect to the angioplasty balloon.
While the foregoing disclosed embodiments comprise filter ribs of a shape memory metal such as nitinol, it will be appreciated that similar results can be obtained by using any suitable resilient material. The ribs would be formed straight, forced open by the balloon, and return to their normal shape as a result of the resiliency of the structure. Or, in the case of the embodiment of
Variations in the design of the filter are also contemplated. For example, while both ends of the ribs 26 of the filter 20 are mounted to rings 22, 24, it will be appreciated that the ends of the ribs at the fixed end of the filter can be secured directly to the catheter shaft.
It will be appreciated that the present invention permits the placement of the embolic filter very close to the means for treating the stenosis. This has the effect of minimizing the “landing area” of the filter and also permits the protection of side branches, as shown in
Finally, it will be understood that the foregoing embodiments have been disclosed by way of example, and that other modifications may occur to those killed in the art without departing from the scope and spirit of the appended claims.
This application is a continuation of currently pending U.S. patent application Ser. No. 11/763,118, filed Jun. 14, 2007, which claims the benefit of Provisional Patent Application No. 60/813,395, filed Jun. 14, 2006. U.S. patent application Ser. No. 11/763,118 is a continuation-in-part of U.S. Pat. No. 8,403,976, filed Nov. 24, 2004. Each of these applications are incorporated by reference in their entireties for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
4723549 | Wholey et al. | Feb 1988 | A |
5053008 | Bajaj | Oct 1991 | A |
5108419 | Reger et al. | Apr 1992 | A |
5456667 | Ham et al. | Oct 1995 | A |
5913895 | Burpee et al. | Jun 1999 | A |
5954745 | Gertler et al. | Sep 1999 | A |
6001118 | Daniel et al. | Dec 1999 | A |
6042598 | Tsugita et al. | Mar 2000 | A |
6051014 | Jang | Apr 2000 | A |
6179859 | Bates et al. | Jan 2001 | B1 |
6168579 | Tsugita | Feb 2001 | B1 |
6325815 | Kusleika et al. | Dec 2001 | B1 |
6344049 | Levinson et al. | Feb 2002 | B1 |
6355051 | Sisskind et al. | Mar 2002 | B1 |
6371970 | Khosravi et al. | Apr 2002 | B1 |
6391044 | Yadav et al. | May 2002 | B1 |
6485502 | Don et al. | Nov 2002 | B2 |
6511496 | Huter et al. | Jan 2003 | B1 |
6511503 | Burkett et al. | Jan 2003 | B1 |
6524303 | Garibaldi | Feb 2003 | B1 |
6537297 | Tsugita et al. | Mar 2003 | B2 |
6592606 | Huter et al. | Jul 2003 | B2 |
6607506 | Kletschka | Aug 2003 | B2 |
6635084 | Israel et al. | Oct 2003 | B2 |
6638294 | Palmer | Oct 2003 | B1 |
6596011 | Johnson et al. | Nov 2003 | B2 |
6652557 | Macdonald | Nov 2003 | B1 |
6656203 | Roth et al. | Dec 2003 | B2 |
6656351 | Boyle | Dec 2003 | B2 |
6663650 | Sepetka et al. | Dec 2003 | B2 |
6682543 | Barbut et al. | Jan 2004 | B2 |
6702834 | Boylan et al. | Mar 2004 | B1 |
6866677 | Douk et al. | Mar 2005 | B2 |
6890340 | Duane | May 2005 | B2 |
6939373 | Gomez et al. | Sep 2005 | B2 |
6964673 | Tsugita et al. | Nov 2005 | B2 |
6969396 | Krolik et al. | Nov 2005 | B2 |
6978174 | Gelfand et al. | Dec 2005 | B2 |
6991641 | Diaz et al. | Jan 2006 | B2 |
6994718 | Groothuis et al. | Feb 2006 | B2 |
7044958 | Douk et al. | May 2006 | B2 |
7083633 | Morrill et al. | Aug 2006 | B2 |
7094249 | Broome et al. | Aug 2006 | B1 |
7097651 | Harrison et al. | Aug 2006 | B2 |
7137991 | Fedie | Nov 2006 | B2 |
7150756 | Levinson et al. | Dec 2006 | B2 |
7163549 | Crank et al. | Jan 2007 | B2 |
7241305 | Ladd | Jul 2007 | B2 |
7338510 | Boylan et al. | Mar 2008 | B2 |
7481823 | Broome et al. | Jan 2009 | B2 |
7653438 | Deem et al. | Jan 2010 | B2 |
7780696 | Daniel et al. | Aug 2010 | B2 |
7935075 | Tockman et al. | May 2011 | B2 |
8150520 | Demarais et al. | Apr 2012 | B2 |
8303617 | Brady et al. | Nov 2012 | B2 |
8372108 | Lashinski | Feb 2013 | B2 |
8403976 | Sachar et al. | Mar 2013 | B2 |
8409240 | Tripp et al. | Apr 2013 | B2 |
8518073 | Lashinski | Aug 2013 | B2 |
8603131 | Gilson et al. | Dec 2013 | B2 |
8657849 | Parker | Feb 2014 | B2 |
8679148 | McGuckin | Mar 2014 | B2 |
8740930 | Goodwin | Jun 2014 | B2 |
8758424 | Sachar et al. | Jun 2014 | B2 |
8852225 | Shu | Oct 2014 | B2 |
8945169 | Pal | Feb 2015 | B2 |
8974490 | Jonsson | Mar 2015 | B2 |
9017364 | Fifer | Apr 2015 | B2 |
9023077 | Cully et al. | May 2015 | B2 |
20010012951 | Bates et al. | Aug 2001 | A1 |
20020123766 | Seguin et al. | Sep 2002 | A1 |
20020156457 | Fisher | Oct 2002 | A1 |
20020173819 | Leeflang et al. | Nov 2002 | A1 |
20030004536 | Boylan et al. | Jan 2003 | A1 |
20030055480 | Fischell et al. | Mar 2003 | A1 |
20030060843 | Boucher | Mar 2003 | A1 |
20030065354 | Boyle et al. | Apr 2003 | A1 |
20030083736 | Brown et al. | May 2003 | A1 |
20030093106 | Brady et al. | May 2003 | A1 |
20030100918 | Duane | May 2003 | A1 |
20030139764 | Levinson et al. | Jul 2003 | A1 |
20030167084 | Orlowski | Sep 2003 | A1 |
20030176884 | Berrada et al. | Sep 2003 | A1 |
20030212361 | Boyle | Nov 2003 | A1 |
20030216792 | Levin et al. | Nov 2003 | A1 |
20030220665 | Eskuri et al. | Nov 2003 | A1 |
20030225435 | Huter et al. | Dec 2003 | A1 |
20040054322 | Vargas | Mar 2004 | A1 |
20040122466 | Bales | Jun 2004 | A1 |
20040158280 | Morris et al. | Aug 2004 | A1 |
20040172128 | Hong et al. | Sep 2004 | A1 |
20040260387 | Regala et al. | Dec 2004 | A1 |
20050015111 | McGuckin et al. | Jan 2005 | A1 |
20050038468 | Panetta et al. | Feb 2005 | A1 |
20050119668 | Teague et al. | Jun 2005 | A1 |
20050228438 | Sachar et al. | Oct 2005 | A1 |
20050288730 | Deem et al. | Dec 2005 | A1 |
20060041277 | Deem et al. | Feb 2006 | A1 |
20060100658 | Obana et al. | May 2006 | A1 |
20060129130 | Tal et al. | Jun 2006 | A1 |
20060129180 | Tsugita et al. | Jun 2006 | A1 |
20060142801 | Demarais et al. | Jun 2006 | A1 |
20060149313 | Arguello | Jul 2006 | A1 |
20060235474 | Demarais | Oct 2006 | A1 |
20070043306 | Olson | Feb 2007 | A1 |
20070061418 | Berg | May 2007 | A1 |
20070167975 | Boyle et al. | Jul 2007 | A1 |
20070299466 | Sachar et al. | Dec 2007 | A1 |
20080097399 | Sachar et al. | Apr 2008 | A1 |
20100106182 | Patel et al. | Apr 2010 | A1 |
20110004291 | Davis et al. | Jan 2011 | A1 |
20110071619 | Bliss et al. | Mar 2011 | A1 |
20120330402 | Vad et al. | Dec 2012 | A1 |
20130031087 | Kropitz et al. | Jan 2013 | A1 |
20130226225 | Sachar et al. | Aug 2013 | A1 |
20130310871 | Sachar et al. | Nov 2013 | A1 |
20140052170 | Heuser et al. | Feb 2014 | A1 |
20140135661 | Garrison et al. | May 2014 | A1 |
20140214067 | Sachar et al. | Jul 2014 | A1 |
20140277383 | Sachar et al. | Sep 2014 | A1 |
20150025567 | Ren et al. | Jan 2015 | A1 |
20150051696 | Hou et al. | Feb 2015 | A1 |
20150133918 | Sachar | May 2015 | A1 |
Number | Date | Country |
---|---|---|
202005022063 | Mar 2013 | DE |
1316292 | Jun 2003 | EP |
2002-336261 | Nov 2002 | JP |
2013-154183 | Aug 2013 | JP |
2004096089 | Nov 2004 | WO |
2005004968 | Jan 2005 | WO |
2007061418 | May 2007 | WO |
2009151761 | Dec 2009 | WO |
2014085590 | Jun 2014 | WO |
2014144787 | Sep 2014 | WO |
2014150013 | Sep 2014 | WO |
2015070147 | May 2015 | WO |
Entry |
---|
Ansel, G.M., et al, “Carotid stenting with embolic protection: evolutionary advances,” Expert Rev Med Devices (Jul. 2008) 5(4):427-436. |
Baim D.S. et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts, Circulation, V. 105, pp. 1285-1290 (2002). |
Barbato, J.E., “A randomized trial of carotid artery stenting with and without cerebral protection,” J Vase Surg (Apr. 2008) 47(4):760-765. |
Bijuklic, K., “The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting): a prospective randomized trial,” J Am Coll Cardiel (Apr. 10, 2012) 59(15): 1383-1389. |
Charalambous, N., et al, “Reduction of cerebral embolization in carotid angioplasty: an in-vitro experiment comparing 2 cerebral protection devices,” J Endovasc Ther (Apr. 2009) 16(2): 161-167. |
Eskandari, M.K., “Cerebral embolic protection,” Semin Vase Surg (Jun. 2005) 18(2):95-100. |
European Search Report dated Oct. 7, 2011, for EP Application No. 05852233.5, which was filed on Nov. 26, 2005, and published as EP 1951147 on Aug. 6, 2008, 7 pages. |
Karada, K., et al, “Significance of combining distal filter protection and a guiding catheter with temporary balloon occlusion for carotid artery stenting: clinical results and evaluation of debris capture,” Ann Vase Surg (Oct. 2012) 26(7): 929-936. |
International Search Report and Written Opinion dated Jun. 28, 2007 for Application No. PCT/US2005/042826, 5 pages. |
International Search Report and Written Opinion dated Nov. 5, 2009 for Application No. PCT/US2009/040202, 6 pages. |
International Search Report and Written Opinion dated Feb. 18, 2014, for Application No. PCT/US2013/072232, which was filed on Nov. 27, 2013, 9 pages. |
International Search Report and Written Opinion dated Jul. 21, 2014, for Application No. PCT/US2014/021850, which was filed on Mar. 7, 2014, (Contego Medical LLC), 6 pages. |
International Search Report and Written Opinion dated Aug. 19, 2014, for Application No. PCT/US2014/029342, which was filed on Mar. 14, 2014 (Contego Medical LLC), 6 pages. |
International Search Report and Written Opinion dated Feb. 23, 2015, for Application No. PCT/US2014/064817, which was filed on Nov. 10, 2014, and published as WO 2015/070147 on May 14, 2015 (Contego Medical LLC), 6 pages. |
Kasirajan, K., et al, “Filter devices for cerebral protection during carotid angioplasty and stenting,” J Endovasc Ther (Dec. 2003) 10(6):1039-1045. |
Kumar et al. “Effects of Design Parameters on the Radial Force of Percutaneous Aortic Valve Stents,” Cardiovasc Revasc Med. Apr.-Jun. 2010; 11(2):101-4. |
Macdonald, S. (2006). Is there any evidence that cerebral protection is beneficial?: Experimental data. Journal of Cardiovascular Surgery, 47(2), 127. |
Mathias, K., “Carotid artery stenting with filters,” J Cardiovasc Surg (Torino) (Feb. 2013) 54(2): 33-39. |
“Mounted,” American Webster Dictionary, http://dictionary.reference.com/browse/mounted, Jan. 28, 2007. |
Muller-Hulsbeck, S., et al, “In vitro comparison of four cerebral protection filters for preventing human plaque embolization during carotid interventions,” J Endovasc Ther (Dec. 2002) 9(6):793-802. |
Ohki, T, “”Critical analysis of distal protection devices,“” Semin Vase Surg (Dec. 2003) 16(4):317-325. |
Order, B.M., et al, “Comparison of 4 cerebral protection filters for carotid angioplasty: an in vitro experiment focusing on carotid anatomy,” J Endovasc Ther (Apr. 2004) 11(2):211-218. |
Supplementary Search Report issued in Application No. 14768559.8, dated Jan. 2, 2017. |
Co-pending U.S. Appl. No. 15/136,060 and its prosecution history. |
Co-pending U.S. Appl. No. 14/865,796 and its prosecution history. |
First Office Action dated Aug. 25, 2016 issued in Chinese Application No. 201480025256.6. |
Second Office Action dated May 18, 2017, issued in Chinese Application No. 201480025256.6. |
Notification of Grant dated Dec. 14, 2017, issued in Chinese Application No. 201480025256.6. |
Communication Pursuant to Article 94(3) EPC, dated Jan. 31, 2017, issued in European Application No. 14768559.8. |
Office Action dated Jan. 9, 2018 issued in Japanese Application No. 2016-500864. |
English Translation of Japanese Office Action issued in JP Application No. 2016-500864, dated Apr. 24, 2018. |
Examination Report issued in Australian Application No. 2014237626, dated Jun. 1, 2018. |
Number | Date | Country | |
---|---|---|---|
20170312069 A1 | Nov 2017 | US |
Number | Date | Country | |
---|---|---|---|
60813395 | Jun 2006 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11763118 | Jun 2007 | US |
Child | 15651429 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10997803 | Nov 2004 | US |
Child | 11763118 | US |